Her main research concerns Internal medicine, Immunology, Rheumatoid arthritis, Endocrinology and Immune system. Her Internal medicine research is multidisciplinary, relying on both Lupus erythematosus, Placebo and Surgery. The Immunology study combines topics in areas such as Molecular biology and Peripheral blood mononuclear cell.
The concepts of her Rheumatoid arthritis study are interwoven with issues in Anemia, Hematocrit, Erythropoietin and Arthritis. Her work on Androgen and Metabolic disorder as part of general Endocrinology research is often related to In patient, thus linking different fields of science. Her Immune system study which covers Antibody that intersects with Spleen and Castration.
Her primary scientific interests are in Immunology, Internal medicine, Rheumatoid arthritis, Immune system and Autoimmune disease. Her Immunology research is multidisciplinary, incorporating perspectives in Systemic lupus erythematosus and Disease. Her Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Lupus erythematosus, Endocrinology and Placebo.
In general Rheumatoid arthritis study, her work on Rheumatoid factor often relates to the realm of In patient, thereby connecting several areas of interest. Her Immune system research incorporates elements of Hormone and Gene expression. Her Autoimmune disease study integrates concerns from other disciplines, such as Systemic disease, Gene and Gene expression profiling.
Immunology, Immune system, Arthritis, Autoimmunity and Cancer research are her primary areas of study. Nancy J. Olsen interconnects Cell and Lupus nephritis in the investigation of issues within Immunology. In most of her Immune system studies, her work intersects topics such as Rheumatoid arthritis.
Her Arthritis study results in a more complete grasp of Internal medicine. Nancy J. Olsen has researched Internal medicine in several fields, including Current Procedural Terminology and Total knee arthroplasty. Her study in Autoimmunity is interdisciplinary in nature, drawing from both Chronic inflammatory disease and C-reactive protein.
Her primary areas of investigation include Immunology, Immune system, FOXP3, Lupus nephritis and Internal medicine. Nancy J. Olsen mostly deals with Autoimmunity in her studies of Immunology. Her Immune system study integrates concerns from other disciplines, such as Inflammation and Autoimmune disease.
Her studies deal with areas such as Transcription, Gene, TIGIT and Rheumatoid arthritis as well as FOXP3. Her work deals with themes such as Calcineurin, Gastroenterology, Mycophenolate, CD8 and Adoptive cell transfer, which intersect with Lupus nephritis. The study of Internal medicine is intertwined with the study of Placebo in a number of ways.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Gerald B. Appel;Gabriel Contreras;Mary Anne Dooley;Ellen M. Ginzler.
Journal of The American Society of Nephrology (2009)
Premature coronary-artery atherosclerosis in systemic lupus erythematosus.
Yu Asanuma;Annette Oeser;Ayumi K. Shintani;Elizabeth Turner.
The New England Journal of Medicine (2003)
Treatment of Active Rheumatoid Arthritis With Leflunomide Compared With Placebo and Methotrexate
Vibeke Strand;Stanley Cohen;Michael Schiff;Arthur Weaver.
JAMA Internal Medicine (1999)
New drugs for rheumatoid arthritis.
Nancy J. Olsen;C. Michael Stein.
The New England Journal of Medicine (2004)
Gonadal steroids and immunity
Nancy J. Olsen;William J. Kovacs.
Endocrine Reviews (1996)
Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue.
Roy A. Fava;Nancy J. Olsen;George Spencer-Green;Kiang Teck Yeo.
Journal of Experimental Medicine (1994)
Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis
Mary Anne Dooley;David Jayne;Ellen M. Ginzler;David Isenberg.
The New England Journal of Medicine (2011)
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate
Stanley Cohen;Grant W. Cannon;Michael Schiff;Arthur Weaver.
Arthritis & Rheumatism (2001)
Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study
Joan T. Merrill;Daniel J. Wallace;Michelle Petri;Kyriakos A. Kirou.
Annals of the Rheumatic Diseases (2011)
Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis.
Theodore Pincus;Nancy J. Olsen;I.Jon Russell;Frederick Wolfe.
The American Journal of Medicine (1990)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: